What is the name of the injectable HIV prevention drug expected to reach low-income countries by 2025?

A)
Truvada
B)
Descovy
C)
Bictegravir
D)
Lenacapavir

Correct Answer :   Lenacapavir


* Lenacapavir is an injectable HIV prevention drug targeted for availability in low-income countries by 2025, pending regulatory approvals from the FDA and WHO.

* It is currently used in the U.S. for drug-resistant HIV but at a high cost.

* Collaborative efforts by organizations like the Global Fund and PEPFAR aim to make it affordable and accessible in resource-limited settings.

Published On : December 18, 2024